» Articles » PMID: 1612758

Interaction of Mycoplasma Dispar with Bovine Alveolar Macrophages

Overview
Journal Infect Immun
Date 1992 Jul 1
PMID 1612758
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The capacity to avoid phagocytosis and the activation of bovine alveolar macrophages (BAM) by encapsulated Mycoplasma dispar or purified M. dispar capsule was investigated. Encapsulated and unencapsulated M. dispar were cocultured with BAM in the presence or absence of antisera prepared against unencapsulated M. dispar or purified capsule antiserum. Unopsonized mycoplasmas resisted phagocytosis, while only anti-capsule antibodies enhanced the phagocytosis of encapsulated mycoplasmas. BAM were cultured in the presence of purified M. dispar capsule or either live or heat-killed encapsulated or unencapsulated M. dispar. These BAM were then activated with Escherichia coli endotoxin or left without further activation. The supernatants of these cultures were assayed for tumor necrosis factor, interleukin 1, and glucose consumption as indicators of macrophage activation. Tumor necrosis factor and interleukin 1 were produced by BAM stimulated with unencapsulated M. dispar but not when encapsulated M. dispar or its purified capsule was used. Similarly, glucose consumption was increased in the presence of unencapsulated M. dispar, but not when BAM were cocultured with encapsulated M. dispar or purified capsule. When BAM were treated with purified capsule or encapsulated mycoplasmas, they could not be subsequently activated by endotoxin. These results indicate that encapsulated M. dispar or purified capsule exerts an inhibitory effect on the activity of BAM and prevents the activation of these cells.

Citing Articles

Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Yiwen C, Yueyue W, Lianmei Q, Cuiming Z, Xiaoxing Y Virulence. 2021; 12(1):788-817.

PMID: 33704021 PMC: 7954426. DOI: 10.1080/21505594.2021.1889813.


The pathogen Shows High Minimum Inhibitory Concentrations for Antimicrobials Commonly Used for Bovine Respiratory Disease.

Bottinelli M, Merenda M, Gastaldelli M, Picchi M, Stefani E, Nicholas R Antibiotics (Basel). 2020; 9(8).

PMID: 32751401 PMC: 7459706. DOI: 10.3390/antibiotics9080460.


Mycoplasma hyopneumoniae evades phagocytic uptake by porcine alveolar macrophages in vitro.

Deeney A, Maglennon G, Chapat L, Crussard S, Jolivet E, Rycroft A Vet Res. 2019; 50(1):51.

PMID: 31234931 PMC: 6591956. DOI: 10.1186/s13567-019-0667-6.


Genome-Wide Analysis of Provides Insights into Putative Virulence Factors and Phylogenetic Relationships.

Chen S, Hao H, Yan X, Liu Y, Chu Y G3 (Bethesda). 2018; 9(2):317-325.

PMID: 30573467 PMC: 6385981. DOI: 10.1534/g3.118.200941.


In vivo role of capsular polysaccharide in Mycoplasma mycoides.

Jores J, Schieck E, Liljander A, Sacchini F, Posthaus H, Lartigue C J Infect Dis. 2018; 219(10):1559-1563.

PMID: 30541131 PMC: 6473168. DOI: 10.1093/infdis/jiy713.


References
1.
Cole B, WARD J . Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages. Infect Immun. 1973; 7(5):691-9. PMC: 422746. DOI: 10.1128/iai.7.5.691-699.1973. View

2.
Jones T, Hirsch J . The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells. J Exp Med. 1971; 133(2):231-59. PMC: 2138893. DOI: 10.1084/jem.133.2.231. View

3.
Almeida R, Rosenbusch R . Capsulelike surface material of Mycoplasma dispar induced by in vitro growth in culture with bovine cells is antigenically related to similar structures expressed in vivo. Infect Immun. 1991; 59(9):3119-25. PMC: 258142. DOI: 10.1128/iai.59.9.3119-3125.1991. View

4.
Pier G, Saunders J, Ames P, Edwards M, Auerbach H, Goldfarb J . Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med. 1987; 317(13):793-8. DOI: 10.1056/NEJM198709243171303. View

5.
Speert D, Wright S, Silverstein S, Mah B . Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa. J Clin Invest. 1988; 82(3):872-9. PMC: 303596. DOI: 10.1172/JCI113692. View